Blog
Apiksaban with a reduced dose turns out to be effective in preventing blood clots in patients with cancer
30
Mar
Mar
Patients with active cancer who developed a blood clot or venous thrombosis (VTE) and were treated with blood thinning drugs for at least six months, and then an additional 12 months of Apiksaban in low dose, experienced similar VTE relapses and less bleeding as similar patients who received a fully dose of oral drugs in […]